|
|||||
|
|
Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment |
|
| Authors: | Joany E. Kreijne Rozanne C. de Veer Nanne K. de Boer Gerard Dijkstra Rachel West Sofia A. W. Moorsel Dirk J. de Jong C. Janneke van der Woude Annemarie C. de Vries |
| Abstract: | |
| Keywords: | adverse events allopurinol hepatotoxicity inflammatory bowel disease myelotoxicity thiopurine |